Loading
Latest filing published 24 Dec 2025 for Alligator Bioscience AB, €30k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Peter Ostler across 3 companies, led by Alligator Bioscience AB, Hoodin AB and Hoodin. Between 19 May 2025 and 18 December 2025, the trades on record add up to 7 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The record was last updated on 24 December 2025 with a transaction (€30k) in Alligator Bioscience AB. Between a trade and the moment it shows up on Finansinspektionen, the median delay is 2 days. For comparison, MAR article 19 gives managers three business days to notify a trade. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations